[PERSON]
JACC: Advances
Featured in 1 tracked story · first seen
Situations
Inclisiran efficacy and evolving LDL cholesterol treatments
3 clusters · 9 sources · last updated
Latest: Cholesterol management: New study results and upcoming oral PCSK9 inhibitor
Research into the efficacy of inclisiran, a drug utilizing small interfering RNA (siRNA) technology to inhibit PCSK9 protein production, has demonstrated significant potential in reducing LDL cholesterol. An initial met